In our study, it was also found that, after overexpression of miR-103a-3p and interference with TRIM66, the glucose consumption and lactate production of DTX-resistant cells were significantly reduced, significantly inhibiting the glycolytic flow of cells, which would slow down the growth of cancer cells and inhibit tumor. This evidence concerns the gene TRIM66 and cancer.